Capital Investment Counsel Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Capital Investment Counsel Inc’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,300	Closed	-$217K	–	137
2015 Q4	$217K	Buy	+3,300	New	+$204K	0.11%	124
2015 Q2	–	Sell	-5,000	Closed	-$312K	–	140
2015 Q1	$312K	Hold	5,000	–	–	0.15%	108
2014 Q4	$288K	Sell	5,000 -2,350	-32%	-$131K	0.14%	114
2014 Q3	$395K	Sell	7,350 -11,975	-62%	-$634K	0.19%	103
2014 Q2	$1.01M	Sell	19,325 -2,500	-11%	-$128K	0.43%	63
2014 Q1	$1.15M	Sell	21,825 -475	-2%	-$22K	0.51%	60
2013 Q4	$894K	Sell	22,300 -7,225	-24%	-$284K	0.41%	69
2013 Q3	$1.11M	Buy	29,525 +400	+1%	+$15.6K	0.55%	54
2013 Q2	$1.14M	Buy	+29,125	New	+$1.13M	0.59%	51

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital Investment Counsel Inc's TEVA Position: Q1 2016 in Review

Capital Investment Counsel Inc sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 3,300 shares — an estimated $217K sold.

Capital Investment Counsel Inc first reported a position in TEVA in Q2 2013 and held it in 9 quarters. The position peaked at $1.15M in Q1 2014. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Capital Investment Counsel Inc reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Capital Investment Counsel Inc sold 3,300 Teva Pharmaceuticals shares in Q1 2016, an estimated $217K.
Capital Investment Counsel Inc first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Capital Investment Counsel Inc's Teva Pharmaceuticals position peaked at $1.15M in Q1 2014.
837 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Capital Investment Counsel Inc's 13F filing for Q1 2016, filed 3 May 2016.